Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
B129900-10mg | 10mg | In stock | $55.90 | |
B129900-50mg | 50mg | In stock | $99.90 | |
B129900-250mg | 250mg | In stock | $450.90 | |
B129900-500mg | 500mg | In stock | $810.90 | |
B129900-1g | 1g | In stock | $1,458.90 |
Synonyms | 1-{4-[2-(Cyclopropylmethoxy)ethyl]phenoxy}-3-[(propan-2-yl)amino]propan-2-ol | NCGC00015159-04 | C75987 | D07526 | NCGC00015159-06 | C07AB05 | GTPL549 | HMS3884L05 | AS-14125 | SCHEMBL23530 | (.+/-.)-1-[p-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropyl |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Betaxolol is a cardioselective β1-adrenergic blocker, as well as an antihypertensive and an antiglaucoma |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of β 1-adrenoceptor;Antagonist of β 2-adrenoceptor |
Note | 250mg、10mg卖完停产,不再备货 |
Product Description | Betaxolol is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Pubchem Sid | 488179698 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488179698 |
IUPAC Name | 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol |
INCHI | InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3 |
InChi Key | NWIUTZDMDHAVTP-UHFFFAOYSA-N |
Canonical SMILES | CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O |
Isomeric SMILES | CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O |
PubChem CID | 2369 |
Molecular Weight | 307.43 |
PubChem CID | 2369 |
---|---|
ChEBI | CHEBI:101354 |
Wikipedia | Betaxolol |
ChEMBL Ligand | CHEMBL423 |
DrugBank Ligand | DB00195 |
BindingDB Ligand | 50026854 |
CAS Registry No. | 63659-18-7 |
PEP | betaxolol |
Reactome Reaction | R-HSA-9609310 |
Reactome Drug | R-ALL-9610994 |
DrugCentral Ligand | 356 |
GPCRdb Ligand | betaxolol |
PubChem SID | 488179698 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2329787 | Certificate of Analysis | Feb 24, 2023 | B129900 |
C2329788 | Certificate of Analysis | Feb 24, 2023 | B129900 |
C2329908 | Certificate of Analysis | Feb 24, 2023 | B129900 |
C2330011 | Certificate of Analysis | Feb 24, 2023 | B129900 |
C2330012 | Certificate of Analysis | Feb 24, 2023 | B129900 |
C2330013 | Certificate of Analysis | Feb 24, 2023 | B129900 |
C2330022 | Certificate of Analysis | Feb 24, 2023 | B129900 |
C2330033 | Certificate of Analysis | Feb 24, 2023 | B129900 |
C2330037 | Certificate of Analysis | Feb 24, 2023 | B129900 |
C2330147 | Certificate of Analysis | Feb 24, 2023 | B129900 |
E1520134 | Certificate of Analysis | Dec 07, 2022 | B129900 |
Solubility | Soluble in Acetone and Chloroform |
---|---|
Melt Point(°C) | 61-63°C |
Pictogram(s) | GHS08, GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H412:Harmful to aquatic life with long lasting effects H302:Harmful if swallowed H361:Suspected of damaging fertility or the unborn child |
Precautionary Statements | P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P301+P317:IF SWALLOWED: Get medical help. P318:if exposed or concerned, get medical advice. |
1. Wu Jia, Xiao Xue, Li Zhenqun, Jia Li. (2019) Enantioseparation of chiral β-blockers using polynorepinephrine-coated nanoparticles and chiral capillary electrophoresis. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 411 (10): (2121-2129). [PMID:30734853] [10.1007/s00216-019-01641-4] |
1. Wu Jia, Xiao Xue, Li Zhenqun, Jia Li. (2019) Enantioseparation of chiral β-blockers using polynorepinephrine-coated nanoparticles and chiral capillary electrophoresis. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 411 (10): (2121-2129). [PMID:30734853] [10.1007/s00216-019-01641-4] |